Royal Bank of Canada
XFOR icon

Royal Bank of Canada’s X4 Pharmaceuticals XFOR Stock Holding History

Royal Bank of Canada’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12K Buy
2,559
+2,444
+2,125% +$10K ﹤0.01% 6601
2026
Q1 		$0 Buy
115
+11
+11% +$41 ﹤0.01% 7751
2025
Q4 		$0 Sell
104
-2,429
-96% -$8.82K ﹤0.01% 7706
2025
Q3 		$9K Sell
2,533
-552
-18% -$1.42K ﹤0.01% 6546
2025
Q2 		$6K Buy
3,085
+2,571
+500% +$10.5K ﹤0.01% 6613
2025
Q1 		$4K Buy
514
+156
+44% +$2.15K ﹤0.01% 6440
2024
Q4 		$8K Sell
358
-293
-45% -$4.67K ﹤0.01% 6420
2024
Q3 		$14K Buy
651
+124
+24% +$2.59K ﹤0.01% 6239
2024
Q2 		$9K Buy
527
+432
+455% +$14.1K ﹤0.01% 6401
2024
Q1 		$4K Sell
95
-1,216
-93% -$33.8K ﹤0.01% 6540
2023
Q4 		$33K Buy
1,311
+710
+118% +$17.3K ﹤0.01% 6158
2023
Q3 		$20K Buy
601
+260
+76% +$11.3K ﹤0.01% 6185
2023
Q2 		$20K Buy
+341
New +$17.5K ﹤0.01% 6226
2022
Q4 		– Sell
-3
Closed – – 7790
2022
Q3 		$0 Buy
+3
New +$104 ﹤0.01% 7935
2021
Q3 		– Sell
-69
Closed -$13K – 7908
2021
Q2 		$13K Buy
69
+12
+21% +$3.02K ﹤0.01% 6781
2021
Q1 		$15K Buy
57
+28
+97% +$7.36K ﹤0.01% 6611
2020
Q4 		$6K Buy
29
+28
+2,800% +$5.5K ﹤0.01% 6601
2020
Q3 		$0 Buy
+1
New +$240 ﹤0.01% 6967
2020
Q2 		– Sell
-3
Closed -$1K – 6946
2020
Q1 		$1K Sell
3
-28
-90% -$7.95K ﹤0.01% 6503
2019
Q4 		$10K Buy
31
+22
+244% +$7.89K ﹤0.01% 6149
2019
Q3 		$3K Buy
+9
New +$3.56K ﹤0.01% 6227
2018
Q4 		– Sell
-1
Closed – – 7162
2018
Q3 		$0 Buy
+1
New +$424 ﹤0.01% 6977

Other funds holding XFOR

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $697M AUM 628.57% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Royal Bank of Canada's XFOR Position: Q2 2026 in Review

Royal Bank of Canada increased its X4 Pharmaceuticals (XFOR) stake by 2,125% in Q2 2026, buying an estimated $10K and bringing the position to 2,559 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #6601.

Royal Bank of Canada first reported a position in XFOR in Q3 2018 and has held it in 22 quarters since. The position peaked at $33K in Q4 2023. 89 funds tracked by Wall St. Rank hold XFOR as of Q2 2026.

  • Royal Bank of Canada held 2,559 shares of X4 Pharmaceuticals worth $12K as of Q2 2026.
  • Royal Bank of Canada bought 2,444 X4 Pharmaceuticals shares in Q2 2026, an estimated $10K.
  • X4 Pharmaceuticals made up ﹤0.01% of Royal Bank of Canada's portfolio in Q2 2026, its #6601 holding.
  • Royal Bank of Canada first reported a position in X4 Pharmaceuticals in Q3 2018 and has held it in 22 quarters since.
  • Royal Bank of Canada's X4 Pharmaceuticals position peaked at $33K in Q4 2023.
  • 89 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q2 2026.

Based on Royal Bank of Canada's 13F filing for Q2 2026, filed 14 Aug 2026.